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Access to biological samples is crucial to the research and development process
that leads to diagnostics, therapeutics, and vaccines to address new and
reemerginginfectious diseases. However, access to biologicalsamples has become
an increasingly substantial barrier to this crucial step in the research and
development process. Governments are increasingly asserting sovereign rights
over biological resources, including human pathogens, insisting that transfer of
biological samples be accompaniedby agreements that specify the benefits those
governments might receive with respect to future biomedicalproducts.
The principal mechanism by which samples are shared under this system is the
materialtransfer agreement (MTA). MTAs are contractsprotected by law. If one
of theirprovisions is notfollowed, the contractis breachedand the wrongedparty
has the right to bring action against the other, such as suingfor damages. MTAs
are used in connection with the transfer of materialsfor safekeepingpurposes (for
instance, storage in gene banks), researchor commercial use.
Internationalresearchcollaborationsin the field of infectious disease increasingly
require researchersto be more extensively knowledgeable aboutMTA negotiations.
Joint ventures and collaborations between scientists in biodiverse but resourcescarce countries in Africa, Asia, and South America are growing in importance to
the identification, sampling, biobanking, and research of potentially human
pathogenic viruses. Identifying these zoonotic viral threats in high-risk areas
where diseases are most likely to emerge raises complex problems of material
acquisition and transfer that may inhibit the research and development process.
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Many biodiverse-rich countriesdo not have well-developed or adequate scientific
capacitiesand resourcesto document and monitor the transferof their biodiversity.
This article analyzes the substantialchanges under way in the global system for
infectious disease researchas embodied by changingpractice in negotiating
MTAs. Instead of the open system of sharingbacterialand viral human
pathogens that characterizedthe researchsystem for much of the 20th Century,
notions of "viralsovereignty", access made contingent on sharingresearch
benefits, and acrimoniousnegotiationsarefar more common. The increasing
barriersto the flow of researchmaterialand relateddata, like genetic sequencing
information, areposing threats to the development of diagnostics, therapeutics,
and vaccines. The article assesses the extent of these barriersandproposes some
win-win approachesthat may address the global inequalitiesbehind material
transfer negotiation issues.
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There is no doubt thatfor countries in Africa, a social health insurance
(SHI) system representsperhaps the best avenue towardachieving
universal health coverage (UHC) - the goal of every health system. First,
the underlying ideology behind SHI, namely, solidarity, is consistent with
African cosmology.
Additionally, because SHI involves a public-privatesector partnershipto raise
fundsfor health care, the system addresses one of the greatest lingering
challengesfacing health systems andfamilies in the region: the risingcost of
health care. These two factors have led to success stories in some countries
(Rwandaand Ghana), in that they have seen significantjumps in access to health
care. But these same factors have also led tofailures in other countries,for
instance, Nigeria. The task of thispaper is to determine not only the reasonsfor
the failure in Nigeriabut also to determine why Rwanda and Ghana are
succeeding. Ultimately, the aim of this paper is to distill experiencesfrom the
success stories and use those lessons to transform health carefinancingin
Nigeriaand other similarly situatedemerging health systems.
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As partof the wave of medical malpracticereforms over the last severaldecades,
efforts were initiatedto ensure the reliabilityand credibilityof expert witness
opinion and testimony, which is the sine qua non of necessaryprooffor any such
claim or lawsuit. Governing bodies ofprofessionalmedical organizationsand
societies have crafted rules and regulationsfor their members that wish to

https://lawecommons.luc.edu/annals/vol28/iss1/1

2

: Table of Contents

provide expert medicalwitness testimony. Where such testimony does not
conform to these organizations'standards, sanctions can be levied, including
membership expulsion. Such self-policing hasfoundfavor with courts.
Before sanctions are imposed, however, necessary administrativeinvestigations
and hearingsare conducted, focusing on the foundation of the organization
member's expert opinions. But in these proceedings, there is a significant
problem which has never been examined or analyzed in the legal literature or in
any publishedappellate court decision: the submission of the patient's medical
information by either the complainingparty or the responding expert in violation
ofHIPAA's Privacy Rule or state privacy laws. This article examines and
confronts the roadblocks to the self-policing mechanisms ofprofessional medical
organizationsthat they present. It concludes by proposingalternative
methodologies and relief that may overcome the legal and regulatory roadblocks
presentedby HIPAA 's PrivacyRule and state laws.
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